Anjarium Biosciences

Anjarium Biosciences is dedicated to developing next-generation non-viral gene therapies. The company's versatile platform aims to leverage breakthrough science and expertise in gene medicine, synthetic biology, and nanoparticle engineering interfaces to generate a series of advanced gene therapies, offering unique competitive advantages compared to current virus vector-based gene therapies.